Please enable JavaScript.
Coggle requires JavaScript to display documents.
Quiz 1 Part 2 - Coggle Diagram
Quiz 1 Part 2
baclofen (Lioresal)
-
common ADRs: nausea, asthenia, dizziness, somnolence, confusion
-
rare ADRs: slowed or difficult breathing when used in combo with opioids, pneumonia, GI hemorrhage, seizure
-
efficacy: reduction in muscle spasm, passive limb movement, pain relief
toxicity: seek medical attention if severe dizziness, confusion, sedation, or rebound spasticity occurs
counseling: because of the possibility of sedation, patients should be cautioned regarding the operation of motor vehicles or dangerous machinery while taking baclofen; patients should be cautioned that CNS effects of baclofen may be additive to those of alcohol and other CNS depressants
carisoprodol (Soma)
interactions: CYP2C19 inhibitors/inducers, CNS depressants (additive sedative effects)
common ADRs: drowsiness, dizziness
-
rare ADRs: slowed or difficult breathing when used in combo with opioids, seizure, drug dependence, withdrawal symptoms upon D/C after chronic use
class: centrally acting muscle relaxant, C-IV
-
toxicity: seek medical attention if idosyncratic symptoms such as extreme weakness, transient quadriplegia, dizziness, confusion occur within minutes to hours after first dose
counseling: patients should avoid consuming EtOH; patients should avoid activities requiring mental alertness or coordination until drug effects are known, as drug may cause dizziness or sedative effects; patients withdrawing from prolonged therapy should be monitored carefully for withdrawal symptoms, including seizures
metaxalone (Skelaxin)
-
rare ADRs: hemolytic anemia, leukopenia, jaundice, immune hypersensitivity reaction, maculopapular rash, slowed or difficulty breathing when used in combo with opioids
-
-
-
-
-
counseling: patients should avoid activities requiring mental alertness or coordination until drug effects are known, as drug may cause dizziness or sedative effects
methocarbamol (Robaxin)
rare ADRs: bradyarrhythmia, hypotension, syncope, leukopenia, anaphylactoid reaction, slowed or difficult breathing when used in combo with opioids
-
-
-
toxicity: seek medical attention if idiosyncratic symptoms such as extreme weakness, transient quadriplegia, dizziness, and confusion occur within minutes or hours after 1st dose; vital signs
-
counseling: patients should avoid activities requiring mental alertness or coordination until drug effects are known, as drug may cause dizziness or sedative effects
-